drug
as of 2026-07-01CYP-1020
at a glance
small molecule
Pre-approval / investigational in the US
Developed by BioLineRx, Ltd.
1 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
Trials
1
Phase IIb-III Study of BL-1020 Small Molecule for Schizophrenia
NCT01363349Phase 2, Phase 3Terminated
KOLs & investigators
1
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here